ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

PMD Psychemedics Corporation

2.55
-0.0863 (-3.27%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Psychemedics Corporation PMD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0863 -3.27% 2.55 23:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.64 2.53 2.64 2.55 2.6363
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
28/3/202407:20GLOBEPsychemedics Corporation Reports 2023 Financial Results
21/3/202408:00GLOBEPsychemedics Recognized as a Top 10 Employee Health Testing..
13/2/202408:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202415:10EDGAR2Form 8-K - Current report
24/1/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202410:27GLOBEPsychemedics Corporation Announces Relocation of..
19/12/202315:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202311:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202310:31EDGAR2Form 8-K - Current report
27/11/202308:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
13/11/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202316:00GLOBEPsychemedics Corporation Reports Third Quarter 2023..
09/11/202316:00EDGAR2Form 8-K - Current report
08/11/202316:00EDGAR2Form 8-K - Current report
27/10/202310:00GLOBEUnveiling the Future of Drug Testing: Psychemedics..
25/9/202317:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202312:00EDGAR2Form 8-K - Current report
21/9/202316:00GLOBEPsychemedics Corporation Appoints Shannon Shoemaker as Chief..
31/8/202316:20EDGAR2Form 8-K - Current report
22/8/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202316:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/8/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202316:01EDGAR2Form 8-K - Current report
18/8/202313:00GLOBEPsychemedics Corporation Reports Inducement Grants Under..
17/8/202316:30EDGAR2Form 144 - Report of proposed sale of securities
14/8/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202316:10GLOBEPsychemedics Corporation Reports Second Quarter 2023..
11/8/202316:10EDGAR2Form 8-K - Current report
21/7/202316:00EDGAR2Form 8-K - Current report
21/7/202315:00EDGAR2Form DEF 14A - Other definitive proxy statements
14/7/202308:15EDGAR2Form 8-K - Current report
12/7/202316:15GLOBEPsychemedics Corporation Announces CEO Succession Plan
09/5/202316:30GLOBEPsychemedics Corporation Reports First Quarter 2023..

Su Consulta Reciente

Delayed Upgrade Clock